Placebo
Placebo pill (no active cannabinoids)
Loading study record…
Loading study record…
The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2025-06-10
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
To characterize the acute effects of oral Dronabinol (10 mg capsule) in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Interventions
Placebo pill (no active cannabinoids)
10 mg capsule of Dronabinol will be administered orally.
Delta-9-TetrahydrocannabinolEligibility
primary outcomes
Time frame: changes in "high" assessed over the following timepoints: baseline, +60, +80, +120, +180, +300 minutes after start of oral Dronabinol administration.
Subjective measure of THC induced "high"
Time frame: baseline and +80 minutes after start of oral Dronabinol administration.
Measured as delay recall on the AVLT
Publications
No exact PMID-linked public article is currently readable locally.